Thomas J. Schaefer - Aug 19, 2024 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Chief Executive Officer
Signature
Thomas J. Schaefer, by Attorney-in-fact, Solaeta Chan
Stock symbol
RKDA
Transactions as of
Aug 19, 2024
Transactions value $
$0
Form type
4
Date filed
8/21/2024, 06:09 PM
Previous filing
Aug 20, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +20K +365.3% $0.00 25.5K Aug 19, 2024 Common Stock 20K $2.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.